De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient.

Autor: Durazo FA; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Kristbaum K; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA., Miller J; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Saeian K; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Selim M; Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA., Hong JC; Division of Transplantation, Pennsylvania State University, College of Medicine Penn State Health Milton S. Hershey Medical Center Hershey, Pennsylvania, USA.
Jazyk: angličtina
Zdroj: Case reports in hepatology [Case Reports Hepatol] 2022 Dec 22; Vol. 2022, pp. 8409269. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2022).
DOI: 10.1155/2022/8409269
Abstrakt: Liver test abnormalities have been described during severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection causing coronavirus disease 2019. Most of them consist of elevation of the aminotransferases that resolve once the infection subsides. There are several reports of autoimmune hepatitis developing after vaccination against COVID-19 and one case of autoimmune hepatitis following COVID-19 infection. We present a patient that was not vaccinated against COVID-19 and developed resistant de novo autoimmune hepatitis following COVID-19 infection requiring aggressive immunosuppression.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2022 Francisco A. Durazo et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje